Order Article Reprints

AL-Quraini M, Rizvi M, AL-Jabri Z, Sami H, AL-Muzahmi M, AL-Muharrmi Z, Taneja N, AL-Busaidi I, Soman R. Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol. Antibiotics. 2022; 11(2):153. https://doi.org/10.3390/antibiotics11020153

AL-Quraini, Manawr, Meher Rizvi, Zaaima AL-Jabri, Hiba Sami, Muna AL-Muzahmi, Zakariya AL-Muharrmi, Neelam Taneja, Ibrahim AL-Busaidi, and Rajeev Soman. 2022. "Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol" Antibiotics 11, no. 2: 153. https://doi.org/10.3390/antibiotics11020153

AL-Quraini, M., Rizvi, M., AL-Jabri, Z., Sami, H., AL-Muzahmi, M., AL-Muharrmi, Z., Taneja, N., AL-Busaidi, I., & Soman, R. (2022). Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol. Antibiotics, 11(2), 153. https://doi.org/10.3390/antibiotics11020153